HNWAG
MRNA icon

High Net Worth Advisory Group’s Moderna MRNA Stock Holding History

High Net Worth Advisory Group’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-125
Closed -$22.5K – 429
2022
Q4 		$22.5K Hold
125
– – 0.01% 427
2022
Q3 		$15K Hold
125
– – 0.01% 489
2022
Q2 		$18K Sell
125
-1
-0.8% -$143 0.01% 470
2022
Q1 		$22K Hold
126
– – 0.01% 443
2021
Q4 		$32K Buy
+126
New +$36.8K 0.01% 396

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

High Net Worth Advisory Group's MRNA Position: Q1 2023 in Review

High Net Worth Advisory Group sold out of Moderna (MRNA) in Q1 2023, closing a stake of 125 shares — an estimated $22.5K sold.

High Net Worth Advisory Group first reported a position in MRNA in Q4 2021 and held it in 5 quarters. The position peaked at $32K in Q4 2021. 1,015 funds tracked by Wall St. Rank hold MRNA as of Q1 2023.

  • High Net Worth Advisory Group reported no remaining Moderna position as of Q1 2023 after selling out during the quarter.
  • High Net Worth Advisory Group sold 125 Moderna shares in Q1 2023, an estimated $22.5K.
  • High Net Worth Advisory Group first reported a position in Moderna in Q4 2021 and held it in 5 quarters.
  • High Net Worth Advisory Group's Moderna position peaked at $32K in Q4 2021.
  • 1,015 funds tracked by Wall St. Rank held Moderna as of Q1 2023.

Based on High Net Worth Advisory Group's 13F filing for Q1 2023, filed 20 Apr 2023.